Comprehensive analysis of N6-methyladenosine regulators with the tumor immune landscape and correlation between the insulin-like growth factor 2 mRNA-binding protein 3 and programmed death ligand 1 in bladder cancer
Abstract Background N6-methyladenosine (m6A) is one of the most abundant post-transcriptional modifications of RNA. However, there is limited information about the potential roles of m6A regulators in tumor immunity. Therefore, in this study, we aimed to testify the functions of m6A regulators in bl...
Main Authors: | Jianfeng Cui, Yaofeng Zhu, Xiaochen Liu, Wenfu Wang, Xuewen Jiang, Yangyang Xia, Guanwen Zhou, Shouzhen Chen, Benkang Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-02-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-022-02456-7 |
Similar Items
-
CircPTPRA blocks the recognition of RNA N 6 -methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression
by: Fei Xie, et al.
Published: (2021-04-01) -
Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer
by: Xinwei Huang, et al.
Published: (2018-06-01) -
IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer
by: Wei Huang, et al.
Published: (2023-02-01) -
Expression and prognostic analyses of the insulin-like growth factor 2 mRNA binding protein family in human pancreatic cancer
by: Xiao-Han Cui, et al.
Published: (2020-11-01) -
Programmed cell death protein 1 and programmed death ligand 1 expression in neuroendocrine carcinomas of the urinary bladder
by: Arbil Acikalin, et al.
Published: (2021-02-01)